Search

The article discusses the prohibitive costs of access to HIV preexposure prophylaxis (PrEP) in the U.S. It examines the role that PrEP plays in HIV prevention, the policy of the U.S. government concerning access to PrEP, and unequal access to PrEP in various sectors of the U.S. population.

Life-saving medications for opioid use disorder are inaccessible for people with human immunodeficiency virus relying on the AIDS Drug Assistance Programs (ADAP) in 40% of jurisdictions. Funding/policies should address this through increasing access through ADAP and the Ryan White HIV/AIDS Program (RWHAP), partnerships between RWHAP and substance use programs, and other state/federal initiatives. [ABSTRACT FROM AUTHOR]

The authors discuss government plans to end the HIV epidemic. They mention the need to draw in new resources and support for such programs, expanded funding of programs that support HIV prevention, and the need for state and local governments to participate in reforming health care to aid the program.